Clinical Trials Browser

imisopasem manganese × Clear all

NCT00101621 2006-02-09

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

Phase 2 Terminated

Neoplasms, Pain

NCT00033956 2005-06-24

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Phase 1/2 Suspended

DermatologicGenitourinary

Carcinoma, Renal Cell, Hypotension, Melanoma